Business Description
ICARES Medicus Inc
ISIN : TW0006612005
Total Employee Number:
47Description
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.89 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.45 | |||||
Debt-to-EBITDA | 3.62 | |||||
Interest Coverage | 4.54 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.59 | |||||
Beneish M-Score | -2.2 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.9 | |||||
3-Year EBITDA Growth Rate | 7.4 | |||||
3-Year EPS without NRI Growth Rate | -30.3 | |||||
3-Year Book Growth Rate | 22.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.29 | |||||
9-Day RSI | 44.24 | |||||
14-Day RSI | 44.74 | |||||
3-1 Month Momentum % | 6.47 | |||||
6-1 Month Momentum % | -11.49 | |||||
12-1 Month Momentum % | -30.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.07 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.9 | |||||
Days Inventory | 315.76 | |||||
Days Sales Outstanding | 103.16 | |||||
Days Payable | 26.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.43 | |||||
Dividend Payout Ratio | 0.39 | |||||
3-Year Dividend Growth Rate | -9.7 | |||||
Forward Dividend Yield % | 0.43 | |||||
5-Year Yield-on-Cost % | 0.54 | |||||
3-Year Average Share Buyback Ratio | -4.3 | |||||
Shareholder Yield % | 0.56 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.53 | |||||
Operating Margin % | 9.55 | |||||
Net Margin % | 3.73 | |||||
EBITDA Margin % | 20.49 | |||||
FCF Margin % | -3.15 | |||||
OCF Margin % | 1.47 | |||||
ROE % | 2.4 | |||||
ROA % | 1.35 | |||||
3-Year ROIIC % | -5.52 | |||||
ROC (Joel Greenblatt) % | 6.61 | |||||
ROCE % | 3.26 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 79.12 | |||||
PE Ratio without NRI | 91.28 | |||||
Shiller PE Ratio | 34.65 | |||||
Price-to-Owner-Earnings | 164.17 | |||||
PEG Ratio | 4.93 | |||||
PS Ratio | 2.93 | |||||
PB Ratio | 1.77 | |||||
Price-to-Tangible-Book | 3.19 | |||||
Price-to-Operating-Cash-Flow | 183.51 | |||||
EV-to-EBIT | 46.42 | |||||
EV-to-EBITDA | 15.17 | |||||
EV-to-Revenue | 3.11 | |||||
EV-to-FCF | -98.63 | |||||
Price-to-GF-Value | 0.41 | |||||
Price-to-Projected-FCF | 3.67 | |||||
Price-to-DCF (Earnings Based) | 4.96 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.19 | |||||
Price-to-Graham-Number | 3.6 | |||||
| Price-to-Net-Current-Asset-Value | 8.38 | |||||
Earnings Yield (Greenblatt) % | 2.15 | |||||
FCF Yield % | -1.08 | |||||
Forward Rate of Return (Yacktman) % | 18.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ICARES Medicus Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,131.952 | ||
| EPS (TTM) (NT$) | 0.886 | ||
| Beta | 0.8273 | ||
| 3-Year Sharpe Ratio | -0.53 | ||
| 3-Year Sortino Ratio | -0.78 | ||
| Volatility % | 31.07 | ||
| 14-Day RSI | 44.74 | ||
| 14-Day ATR (NT$) | 1.628927 | ||
| 20-Day SMA (NT$) | 71.96 | ||
| 12-1 Month Momentum % | -30.14 | ||
| 52-Week Range (NT$) | 66 - 110.5 | ||
| Shares Outstanding (Mil) | 47.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ICARES Medicus Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ICARES Medicus Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.300000 Cash Dividend | 2025-08-22 | 98.18 (+1.89%) | ||
| 1.1:1 Stock Split | 2025-08-22 | 98.18 (+1.89%) | ||
| 1.1:1 Stock Split | 2024-07-08 | 142.15 (-2.27%) |
Show
Entries
ICARES Medicus Inc Frequently Asked Questions
What is ICARES Medicus Inc(ROCO:6612)'s stock price today?
The current price of ROCO:6612 is NT$70.10. The 52 week high of ROCO:6612 is NT$110.50 and 52 week low is NT$66.00.
When is next earnings date of ICARES Medicus Inc(ROCO:6612)?
The next earnings date of ICARES Medicus Inc(ROCO:6612) is .
Does ICARES Medicus Inc(ROCO:6612) pay dividends? If so, how much?
The Dividend Yield %  of ICARES Medicus Inc(ROCO:6612) is 0.43% (As of Today), Highest Dividend Payout Ratio of ICARES Medicus Inc(ROCO:6612) was 0.39. The lowest was 0.06. And the median was 0.2. The  Forward Dividend Yield % of ICARES Medicus Inc(ROCO:6612) is 0.43%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on ICARES Medicus Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers